Header Logo

Connection

Steven Feinstein to Humans

Back to Details
This is a "connection" page, showing publications Steven Feinstein has written about Humans.
Steven Feinstein
Connection Strength
1.020
Humans
  1. Contrast-enhanced ultrasound in pediatric echocardiography. Pediatr Radiol. 2021 Nov; 51(12):2408-2417.
    View in: PubMed
    Score: 0.041
  2. Introduction: 4th Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM and FLAUS. Ultrasound Med Biol. 2020 12; 46(12):3483-3484.
    View in: PubMed
    Score: 0.039
  3. Contrast-Enhanced Ultrasound to Assess Carotid Intraplaque Neovascularization. Ultrasound Med Biol. 2020 03; 46(3):466-478.
    View in: PubMed
    Score: 0.037
  4. Takotsubo cardiomyopathy in a man with no trigger and multiple cardioembolic complications-A rare constellation. Echocardiography. 2019 May; 36(5):975-979.
    View in: PubMed
    Score: 0.035
  5. Use of ultrasound enhancing agents in transesophageal echocardiography to improve interpretive confidence of left atrial appendage thrombus. Echocardiography. 2019 02; 36(2):362-369.
    View in: PubMed
    Score: 0.034
  6. Drug and Gene Delivery using Sonoporation for Cardiovascular Disease. Adv Exp Med Biol. 2016; 880:331-8.
    View in: PubMed
    Score: 0.028
  7. The Use of Contrast-enhanced Ultrasonography for Imaging of Carotid Atherosclerotic Plaques: Current Evidence, Future Directions. Neuroimaging Clin N Am. 2016 Feb; 26(1):81-96.
    View in: PubMed
    Score: 0.028
  8. Carotid adventitial vasa vasorum and intima-media thickness in a primary prevention population. Echocardiography. 2015 Feb; 32(2):264-70.
    View in: PubMed
    Score: 0.025
  9. Ultrasound-directed, site-specific gene delivery. Methods Mol Biol. 2014; 1141:67-76.
    View in: PubMed
    Score: 0.024
  10. Safety of contrast-enhanced ultrasound in children for non-cardiac applications: a review by the Society for Pediatric Radiology (SPR) and the International Contrast Ultrasound Society (ICUS). Pediatr Radiol. 2013 Sep; 43(9):1063-73.
    View in: PubMed
    Score: 0.024
  11. Safety of ultrasound contrast agents in patients with known or suspected cardiac shunts. Am J Cardiol. 2013 Oct 01; 112(7):1039-45.
    View in: PubMed
    Score: 0.023
  12. Ultrasound-mediated targeted drug delivery: recent success and remaining challenges. Am J Physiol Heart Circ Physiol. 2013 Feb 01; 304(3):H350-7.
    View in: PubMed
    Score: 0.023
  13. More on advances in imaging angiogenesis and inflammation in atherosclerosis. Thromb Haemost. 2011 May; 105(5):920-1.
    View in: PubMed
    Score: 0.020
  14. Predictors of anterior and posterior wall carotid intima media thickness progression in men and women at moderate risk of coronary heart disease. J Clin Lipidol. 2011 May-Jun; 5(3):141-151.
    View in: PubMed
    Score: 0.020
  15. New advances in noninvasive imaging of the carotid artery: CIMT, contrast-enhanced ultrasound, and vasa vasorum. Curr Cardiol Rep. 2010 Nov; 12(6):497-502.
    View in: PubMed
    Score: 0.020
  16. Correlation of carotid artery atherosclerotic lesion echogenicity and severity at standard US with intraplaque neovascularization detected at contrast-enhanced US. Radiology. 2011 Feb; 258(2):618-26.
    View in: PubMed
    Score: 0.019
  17. Contrast-enhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques. JACC Cardiovasc Imaging. 2010 Jul; 3(7):761-71.
    View in: PubMed
    Score: 0.019
  18. Contrast enhanced ultrasound imaging. J Nucl Cardiol. 2010 Jan-Feb; 17(1):106-15.
    View in: PubMed
    Score: 0.018
  19. Vasa vasorum and plaque neovascularization on contrast-enhanced carotid ultrasound imaging correlates with cardiovascular disease and past cardiovascular events. Stroke. 2010 Jan; 41(1):41-7.
    View in: PubMed
    Score: 0.018
  20. Carotid intima-media thickness measurements: techniques and clinical relevance. Curr Atheroscler Rep. 2008 Oct; 10(5):444-50.
    View in: PubMed
    Score: 0.017
  21. Arterial microvessels: an early or late sign of atherosclerosis? J Am Coll Cardiol. 2008 Sep 09; 52(11):968; author reply 968-9.
    View in: PubMed
    Score: 0.017
  22. Imaging of the vasa vasorum. Nat Clin Pract Cardiovasc Med. 2008 Aug; 5 Suppl 2:S18-25.
    View in: PubMed
    Score: 0.017
  23. Contrast-enhanced ultrasound imaging of atherosclerotic carotid plaque neovascularization: a new surrogate marker of atherosclerosis? Vasc Med. 2007 Nov; 12(4):291-7.
    View in: PubMed
    Score: 0.016
  24. Diabetes mellitus and noninvasive imaging of atherosclerosis. Am J Cardiol. 2007 Feb 19; 99(4A):89B-95B.
    View in: PubMed
    Score: 0.015
  25. Contrast ultrasound imaging of the carotid artery vasa vasorum and atherosclerotic plaque neovascularization. J Am Coll Cardiol. 2006 Jul 18; 48(2):236-43.
    View in: PubMed
    Score: 0.014
  26. The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond. Am J Physiol Heart Circ Physiol. 2004 Aug; 287(2):H450-7.
    View in: PubMed
    Score: 0.013
  27. Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy. Am J Cardiol. 2004 Jun 03; 93(11A):32C-48C.
    View in: PubMed
    Score: 0.013
  28. Effect of contrast enhancement on measurement of carotid artery intimal medial thickness. Vasc Med. 2004 Feb; 9(1):7-12.
    View in: PubMed
    Score: 0.012
  29. Emerging, noninvasive surrogate markers of atherosclerosis. Curr Atheroscler Rep. 2004 Jan; 6(1):60-8.
    View in: PubMed
    Score: 0.012
  30. Comparison of echocardiography using tissue harmonics and contrast harmonics with radionuclide angiography for the assessment of left ventricular function. J Investig Med. 2003 Nov; 51(6):366-72.
    View in: PubMed
    Score: 0.012
  31. 3D-Arterial analysis software and CEUS in the assessment of severity and vulnerability of carotid atherosclerotic plaque: a comparison with CTA and histopathology. Radiol Med. 2022 Nov; 127(11):1254-1269.
    View in: PubMed
    Score: 0.011
  32. Noninvasive surrogate markers of atherosclerosis. Am J Cardiol. 2002 Mar 07; 89(5A):31C-43C; discussion 43C-44C.
    View in: PubMed
    Score: 0.011
  33. A retrospective experience of right atrial and superior vena caval thrombi diagnosed by transesophageal echocardiography. J Am Soc Echocardiogr. 2002 Jan; 15(1):76-9.
    View in: PubMed
    Score: 0.011
  34. Plaque Elasticity and Intraplaque Neovascularisation on Carotid Artery Ultrasound: A Comparative Histological Study. Eur J Vasc Endovasc Surg. 2021 09; 62(3):358-366.
    View in: PubMed
    Score: 0.010
  35. Pediatric contrast-enhanced ultrasound: shedding light on the pursuit of approval in the United States. Pediatr Radiol. 2021 Nov; 51(12):2128-2138.
    View in: PubMed
    Score: 0.010
  36. Recommendations for the Assessment of Carotid Arterial Plaque by Ultrasound for the Characterization of Atherosclerosis and Evaluation of Cardiovascular Risk: From the American Society of Echocardiography. J Am Soc Echocardiogr. 2020 08; 33(8):917-933.
    View in: PubMed
    Score: 0.010
  37. Visualizing false lumen perfusion using sonicated albumin microspheres in aortic dissection repair: a state of the art application of contrast echocardiography and echoaortography. Crit Care Med. 2000 Jun; 28(6):2147-9.
    View in: PubMed
    Score: 0.009
  38. Benefits, Open questions and Challenges of the use of Ultrasound in?the COVID-19 pandemic era. The views of a panel of worldwide international experts. Ultraschall Med. 2020 06; 41(3):228-236.
    View in: PubMed
    Score: 0.009
  39. New Applications in Echocardiography for Ultrasound Contrast Agents in the 21st Century. Ultrasound Med Biol. 2020 05; 46(5):1071-1081.
    View in: PubMed
    Score: 0.009
  40. Carotid intraplaque neovascularization predicts coronary artery disease and cardiovascular events. Eur Heart J Cardiovasc Imaging. 2019 Nov 01; 20(11):1239-1247.
    View in: PubMed
    Score: 0.009
  41. Reciprocal Multifaceted Interaction Between HDL (High-Density Lipoprotein) and Myocardial Infarction. Arterioscler Thromb Vasc Biol. 2019 08; 39(8):1550-1564.
    View in: PubMed
    Score: 0.009
  42. HDL-Targeted Therapies During Myocardial Infarction. Cardiovasc Drugs Ther. 2019 06; 33(3):371-381.
    View in: PubMed
    Score: 0.009
  43. Contrast echocardiography: review and future directions. Am J Cardiol. 1998 Jun 18; 81(12A):41G-48G.
    View in: PubMed
    Score: 0.008
  44. Authors' Reply. J Am Soc Echocardiogr. 2017 07; 30(7):724-726.
    View in: PubMed
    Score: 0.008
  45. Contrast echocardiography displays increased subendocardial perfusion after nitroglycerin administration. J Am Soc Echocardiogr. 1997 Apr; 10(3):210-4.
    View in: PubMed
    Score: 0.008
  46. In-hospital statin underutilization among high-risk patients: delayed uptake of the 2013 cholesterol guidelines in a U.S. cohort. Hosp Pract (1995). 2017 Feb; 45(1):16-20.
    View in: PubMed
    Score: 0.008
  47. Reduced forward output states affect the left ventricular opacification of intravenously administered Albunex. J Am Soc Echocardiogr. 1997 Jan-Feb; 10(1):25-30.
    View in: PubMed
    Score: 0.007
  48. Optimizing albunex in the left ventricle: an analysis of the technical parameters of four ultrasound systems in canines and humans. J Am Soc Echocardiogr. 1996 Nov-Dec; 9(6):787-94.
    View in: PubMed
    Score: 0.007
  49. Loss of contrast intensity during systole in the left ventricular cavity with the use of the contrast agent Albunex. An analysis of its correlation with pressure and velocity. Invest Radiol. 1996 Jul; 31(7):415-22.
    View in: PubMed
    Score: 0.007
  50. Detection of Carotid Atherosclerotic Plaque Neovascularization Using Contrast Enhanced Ultrasound: A Systematic Review and Meta-Analysis of Diagnostic Accuracy Studies. J Am Soc Echocardiogr. 2016 06; 29(6):491-502.
    View in: PubMed
    Score: 0.007
  51. Transient Ischemic Attack Caused by Contrast Echocardiography in a Patient with Platypnea-Orthodeoxia. Echocardiography. 2016 Jan; 33(1):165-6.
    View in: PubMed
    Score: 0.007
  52. Retrograde cardioplegia does not adequately perfuse the right ventricle. J Thorac Cardiovasc Surg. 1995 Jun; 109(6):1116-24; discussion 1124-6.
    View in: PubMed
    Score: 0.007
  53. Flow-mediated dilation: An evolving method. Atherosclerosis. 2015 Jul; 241(1):143-4.
    View in: PubMed
    Score: 0.007
  54. Therapeutic ultrasound: Increased HDL-Cholesterol following infusions of acoustic microspheres and apolipoprotein A-I plasmids. Atherosclerosis. 2015 Jul; 241(1):92-9.
    View in: PubMed
    Score: 0.007
  55. Chronic PM2.5 exposure and inflammation: determining sensitive subgroups in mid-life women. Environ Res. 2014 Jul; 132:168-75.
    View in: PubMed
    Score: 0.006
  56. Contrast echocardiography. Ultrasound Med Biol. 1994; 20(6):507-15.
    View in: PubMed
    Score: 0.006
  57. The role of carotid ultrasound in assessing carotid atherosclerosis in individuals at low-to-intermediate cardiovascular risk. Rev Esp Cardiol (Engl Ed). 2013 Dec; 66(12):929-34.
    View in: PubMed
    Score: 0.006
  58. A comparison of methods for the detection of myocardial ischemia during noncardiac surgery: automated ST-segment analysis systems, electrocardiography, and transesophageal echocardiography. Anesth Analg. 1992 Nov; 75(5):764-72.
    View in: PubMed
    Score: 0.006
  59. Advances in contrast echocardiography: intraoperative perfusion assessment. Am J Physiol Imaging. 1992 Jul-Dec; 7(3-4):155-9.
    View in: PubMed
    Score: 0.005
  60. Myocardial perfusion: contrast echocardiography perspectives. Am J Cardiol. 1992 Jun 18; 69(20):36H-41H.
    View in: PubMed
    Score: 0.005
  61. Contrast-enhanced ultrasound for assessing carotid atherosclerotic plaque lesions. AJR Am J Roentgenol. 2012 Jan; 198(1):W13-9.
    View in: PubMed
    Score: 0.005
  62. Detection of adventitial vasa vasorum and intraplaque neovascularization in carotid atherosclerotic lesions with contrast-enhanced ultrasound and their role in atherosclerosis. Methodist Debakey Cardiovasc J. 2011 Oct-Dec; 7(4):37-40.
    View in: PubMed
    Score: 0.005
  63. The ongoing development of contrast echocardiography: its promise for myocardial perfusion assessment. Am J Card Imaging. 1991 Sep; 5(3):188-91.
    View in: PubMed
    Score: 0.005
  64. Noninvasive imaging of the vulnerable atherosclerotic plaque. Curr Probl Cardiol. 2010 Nov; 35(11):556-91.
    View in: PubMed
    Score: 0.005
  65. Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques? J Nucl Cardiol. 2010 Oct; 17(5):897-912.
    View in: PubMed
    Score: 0.005
  66. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results. J Am Coll Cardiol. 1990 Aug; 16(2):316-24.
    View in: PubMed
    Score: 0.005
  67. A retrospective comparison of mortality in critically ill hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent. JACC Cardiovasc Imaging. 2010 Jun; 3(6):578-85.
    View in: PubMed
    Score: 0.005
  68. Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease. Am J Cardiol. 2009 Oct 01; 104(7):936-42.
    View in: PubMed
    Score: 0.005
  69. Transesophageal echocardiography. J Am Soc Echocardiogr. 1989 Sep-Oct; 2(5):354-7.
    View in: PubMed
    Score: 0.004
  70. Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes. Diabetes Care. 2009 Oct; 32(10):1916-20.
    View in: PubMed
    Score: 0.004
  71. Cerebral vasculitis and hemorrhage in an adolescent taking diet pills containing phenylpropanolamine: case report and review of literature. Pediatrics. 1989 May; 83(5):737-41.
    View in: PubMed
    Score: 0.004
  72. Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes. Diabetes Care. 2009 May; 32(5):932-7.
    View in: PubMed
    Score: 0.004
  73. Contrast-enhanced ultrasound imaging of periadventitial vasa vasorum in human carotid arteries. Eur J Echocardiogr. 2009 Mar; 10(2):260-4.
    View in: PubMed
    Score: 0.004
  74. Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes. Diabetes. 2008 Aug; 57(8):2022-7.
    View in: PubMed
    Score: 0.004
  75. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus. Circulation. 2008 Apr 22; 117(16):2123-30.
    View in: PubMed
    Score: 0.004
  76. Contrast echocardiography during coronary arteriography in humans: perfusion and anatomic studies. J Am Coll Cardiol. 1988 Jan; 11(1):59-65.
    View in: PubMed
    Score: 0.004
  77. Individual assessment of arteriosclerosis by empiric clinical profiling. PLoS One. 2007 Nov 28; 2(11):e1215.
    View in: PubMed
    Score: 0.004
  78. Effect of intracoronary injections of sonicated microbubbles on left ventricular contractility. Am J Cardiol. 1987 Jul 01; 60(1):166-71.
    View in: PubMed
    Score: 0.004
  79. The use of contrast echocardiography for the detection of cardiac shunts. Eur J Echocardiogr. 2007 Jun; 8(3):S2-12.
    View in: PubMed
    Score: 0.004
  80. Relationship of traditional and nontraditional cardiovascular risk factors to coronary artery calcium in type 2 diabetes. Diabetes. 2007 Mar; 56(3):849-55.
    View in: PubMed
    Score: 0.004
  81. Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial. JAMA. 2006 Dec 06; 296(21):2572-81.
    View in: PubMed
    Score: 0.004
  82. Myocardial perfusion imaging: contrast echocardiography today and tomorrow. J Am Coll Cardiol. 1986 Jul; 8(1):251-3.
    View in: PubMed
    Score: 0.004
  83. Quantitation of echo-contrast effects. Am J Physiol Imaging. 1986; 1(3):124-8.
    View in: PubMed
    Score: 0.003
  84. Advances in contrast two-dimensional echocardiography. Cardiovasc Clin. 1986; 17(1):95-102.
    View in: PubMed
    Score: 0.003
  85. Two-dimensional contrast echocardiography. I. In vitro development and quantitative analysis of echo contrast agents. J Am Coll Cardiol. 1984 Jan; 3(1):14-20.
    View in: PubMed
    Score: 0.003
  86. Contrast echocardiography: current and future applications. J Am Soc Echocardiogr. 2000 Apr; 13(4):331-42.
    View in: PubMed
    Score: 0.002
  87. Coacervate microspheres as carriers of recombinant adenoviruses. Cancer Gene Ther. 1999 Mar-Apr; 6(2):107-12.
    View in: PubMed
    Score: 0.002
  88. Use of an intravenous contrast agent (Optison) to enhance echocardiography: efficacy and cost implications. Optison Multicenter Study Group. Am J Manag Care. 1998 Sep 25; 4 Spec No:SP169-76.
    View in: PubMed
    Score: 0.002
  89. Tissue-type plasminogen activator therapy versus primary coronary angioplasty: impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction. J Am Coll Cardiol. 1998 Feb; 31(2):338-43.
    View in: PubMed
    Score: 0.002
  90. Perfusion imaging with contract echocardiography: assessment of the no-reflow phenomenon. Coron Artery Dis. 1995 Aug; 6(8):619-24.
    View in: PubMed
    Score: 0.002
  91. Safety and feasibility of renal blood flow determination during kidney transplant surgery with perfusion ultrasonography. Anesth Analg. 1995 Feb; 80(2):353-9.
    View in: PubMed
    Score: 0.002
  92. The relationship between immediate outcome after cardiac surgery, homogeneous cardioplegia delivery, and ejection fraction. Chest. 1994 Jul; 106(1):38-45.
    View in: PubMed
    Score: 0.002
  93. Pitfalls in quantitative contrast echocardiography: the steps to quantitation of perfusion. J Am Soc Echocardiogr. 1993 Jul-Aug; 6(4):395-416.
    View in: PubMed
    Score: 0.001
  94. Myocardial distribution of cardioplegic solution after retrograde delivery in patients undergoing cardiac surgical procedures. J Thorac Cardiovasc Surg. 1993 Feb; 105(2):214-21.
    View in: PubMed
    Score: 0.001
  95. Assessment of myocardial perfusion during CABG surgery with two-dimensional transesophageal contrast echocardiography. Anesthesiology. 1991 Sep; 75(3):433-40.
    View in: PubMed
    Score: 0.001
  96. Right heart dysfunction, pulmonary embolism, and paradoxical embolization during liver transplantation. A transesophageal two-dimensional echocardiographic study. Anesth Analg. 1989 Jun; 68(6):777-82.
    View in: PubMed
    Score: 0.001
  97. Myocardial contrast echocardiography: a new asset for the cath lab. Cardiologia. 1989 May; 34(5):389-98.
    View in: PubMed
    Score: 0.001
  98. Automated production and analysis of echo contrast agents. J Ultrasound Med. 1986 Sep; 5(9):493-8.
    View in: PubMed
    Score: 0.001
  99. Contrast echocardiography for evaluation of myocardial perfusion: effects of coronary angioplasty. J Am Coll Cardiol. 1986 Jul; 8(1):232-5.
    View in: PubMed
    Score: 0.001
  100. Physical factors influencing quantitation of two-dimensional contrast echo amplitudes. J Am Coll Cardiol. 1984 Jul; 4(1):157-64.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.